Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCSL.L Regulatory News (CCSL)

  • There is currently no data for CCSL

Brexit Impact

28 Jun 2016 12:30

RNS Number : 4981C
Chenavari Capital Solutions Limited
28 June 2016
 

28 June 2016

Chenavari Capital Solutions Limited (the "Company")

Brexit Impact on Chenavari Capital Solutions Limited

Market Commentary

Last week, the United Kingdom voted in a referendum to leave the European Union. Significant uncertainties exist on the exit process and the consequences of such decision.

Since this decision, markets have been characterized by extreme volatility in forex and equity, and credit markets are significantly down.

Portfolio Outlook

While we do not expect immediate, direct consequences on the underlying credits in the portfolio, two positions stand out as being highly correlated to the performance of the UK economy:

· A secondary investment in a second loss regulatory capital transaction backed by UK residential mortgages: this transaction has de-levered significantly as it is referencing a static pool of loans. Credit losses continue to be minimal with cumulative losses over 3.2 years at 15.2bps against a second loss representing a 2.19% to 9.87% tranche. While higher unemployment and lower house prices would result in an increase in defaults and losses, the transaction has significant cushion over our base case scenario. This investment represents 5.8% of the Company's NAV as of May month-end.

· A primary investment in a first loss regulatory capital transaction issued by a UK clearing bank referencing large UK corporate borrowers. The transaction is a 0% to 9.6% tranche on a portfolio of £1.86 bn. The underlying corporate borrowers are primarily large UK companies which might be significantly affected by a recession in the UK. No credit event had been recorded in the portfolio as of the March report. This investment represents approximately 11.1% of the Company's NAV as of May month-end.

Impact on the Company

Beyond the two transactions discussed above, the Company's return and NAV might be affected by:

· Marks - We expect a number of capital relief transactions month-end marks to be significantly adversely affected by the extreme volatility and current widening in credit spreads. Approximately 59.7% of the Company's assets are valued on the basis of a dealer valuation and we believe this will result in a reduction in the Company's NAV but it is not possible to estimate the extent of this.

· Hedges and cash collateral - The Company's assets are primarily denominated in currencies other than Sterling. The Company owns assets denominated in Euros, US Dollars and Swiss Francs (together 65.3% of NAV as of May month-end), while the shares were issued in Sterling. Hence, the Company has entered into foreign exchange short-dated swaps to hedge the currency risk.

As of 24 June, the Company held £13m of unencumbered cash, which is available to meet any margin call requirements on its hedges.

Enquiries:

 

Kirstie McLaren

Chenavari Investment Managers

Email: ccslir@chenavari.com

Telephone: +44 20 7259 3600

 

Robert Peel

Fidante Capital

Telephone: +44 20 7832 0900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFPMMTMBITBMF
Date   Source Headline
20th Jul 20185:00 pmRNSFactsheet Available - June 2018
20th Jul 20189:30 amRNSNet Asset Value(s)
26th Jun 20185:45 pmRNSFactsheet Available - May 2018
18th Jun 201810:30 amRNSNet Asset Value(s)
4th Jun 201811:30 amRNSFactsheet Available - April 2018
25th May 20187:00 amRNSHalf-year Report
22nd May 20184:30 pmRNSNet Asset Value(s)
1st May 20187:00 amRNSPartial Compulsory Redemption of Shares
25th Apr 20185:55 pmRNSFactsheet Available - March 2018
20th Apr 20187:00 amRNSDividend Declaration
16th Apr 20184:30 pmRNSPartial Compulsory Redemption of Shares
16th Apr 20184:15 pmRNSNet Asset Value(s)
28th Mar 20185:00 pmRNSResult of AGM
26th Mar 201810:30 amRNSFactsheet Available - February 2018
20th Mar 20182:45 pmRNSNet Asset Value(s)
27th Feb 201812:00 pmRNSFactsheet Available - January 2018
22nd Feb 201812:00 pmRNSNet Asset Value(s)
16th Feb 20185:00 pmRNSNotice of AGM
26th Jan 20185:00 pmRNSDividend Declaration
24th Jan 20184:30 pmRNSFactsheet Available - December 2017
19th Jan 20185:45 pmRNSNet Asset Value(s)
12th Jan 20185:33 pmRNSAnnual Financial Report
11th Jan 20185:42 pmRNSKey Information Document
2nd Jan 201810:00 amRNSFactsheet Available - November 2017
20th Dec 20174:45 pmRNSNet Asset Value(s)
12th Dec 20174:30 pmRNSHolding(s) in Company
5th Dec 201711:30 amRNSFactsheet Available - October 2017
1st Dec 20177:00 amRNSPartial Compulsory Redemption of Shares
15th Nov 20175:00 pmRNSPartial Compulsory Redemption of Shares
15th Nov 20174:40 pmRNSNet Asset Value(s)
27th Oct 201710:00 amRNSFactsheet Available - September 2017
20th Oct 20172:00 pmRNSDividend Declaration
20th Oct 20172:00 pmRNSNet Asset Value(s)
9th Oct 20175:00 pmRNSQuarterly Investor Call
26th Sep 20175:30 pmRNSFactsheet Available - August 2017
25th Sep 20175:30 pmRNSHolding(s) in Company
20th Sep 20173:30 pmRNSNet Asset Value(s)
1st Sep 20177:00 amRNSPartial Compulsory Redemption of Shares
24th Aug 201712:15 pmRNSFactsheet Available - July 2017
17th Aug 201712:00 pmRNSPartial Compulsory Redemption of Shares
16th Aug 20177:00 amRNSNet Asset Value(s)
26th Jul 201712:00 pmRNSFactsheet Available - June 2017
26th Jul 20177:00 amRNSDividend Declaration
19th Jul 20174:15 pmRNSNet Asset Value(s)
4th Jul 20174:00 pmRNSQuarterly Investor Call
23rd Jun 20174:30 pmRNSFactsheet Available - May 2017
20th Jun 20173:00 pmRNSNet Asset Value(s)
25th May 20177:00 amRNSHalf-year Report
23rd May 20174:15 pmRNSFatcsheet Available
17th May 20172:30 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.